Fundamental Data for WST

West Pharmaceutical Services applies technologies to the process of bringing new drug therapies and healthcare products. West''s technologies include the design and manufacture of packaging components for pharmaceutical, healthcare and consumer products; research and development of drug delivery systems; contract manufacturing and packaging services; clinical services; and contract laboratory services and other services that support the manufacturing, filling and packaging of pharmaceutical, healthcare and consumer products.

# Employees: 6300

Address: 101 Gordon Drive P.O. Box 645,Lionville,PA,USA

Phone: 610-594-2900

Fax: 610-594-3000

Website: www.westpharma.com

Email: Mike_Anderson@westpharma.com

Sector: Medical

Industry: MED/DENTAL-SUPP

Executive Officers

Donald E. Morel Jr. (Chmn.; C.E.O.)

Steven A. Ellers (Presi.; C.O.O.)

William J. Federici (V.P.; C.F.O.)

Joseph E. Abbott (V.P.; Corp. Contro.)

John R. Gailey III (V.P.; Gen Consl.; Sec.,)

Dividend

Ex-Dividend Date: 10/19/2009

Annual Dividend: $0.64

Current Dividend Yield: $1.66

Dividend Paid (3 months): $0.16

Indicated Dividend: $0.30

Earnings

Last Earnings Date: 9/30/2009

Next Earnings Date(Expected): 2/18/2010

Mean EPS (Next Qtr): $0.64

Mean EPS (Year): $2.09

Mean Estimate(Long Term): $20.00

P/E Ratio(Based on EPS estimate): 18.450

Number of Estimates: 5

Shares Performance

Period	WST	Compare to S&P
YTD	2.28 %	-15.36 %
4 Weeks	-2.13 %	-7.09 %
12 Weeks	-4.88 %	-11.42 %

Shares Information

Analyst Coverage: Y

Avg Volume: 196496

Shares Outstanding: 32M

Market Cap: $1.27B

52 Week High: $41.52

52 Week Low: $28.12

P/E Ratio: 19.220

PEG Ratio: 0.920

Split: On 9/30/2004 WST split by factor of 2.000

Earnings Performance

EPS Growth in Last Quarter: -22.41 %

EPS Growth in Last Year: 21.62 %

Sales Growth in Last Quarter: -0.80 %

Sales Growth in Last Quarter: 1.05 %

Financials

Qtr Book Value: $2.25

Cash Flow/Share: $8.81

Change in Payout Ratio: 0.010

Price/Sales: 1.260